世界のドライアイ治療薬市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global Dry Eye Medication Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO19278)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO19278
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:107
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のドライアイ治療薬市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

ドライアイ治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のドライアイ治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

ドライアイ治療薬市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・抗炎症薬、人工涙液、涙点プラグ、分泌促進薬、その他

用途別セグメントは次のように区分されます。
・病院、薬局、眼科クリニック、小売店、オンライン薬局

世界のドライアイ治療薬市場の主要な市場プレーヤーは以下のとおりです。
・EyeGate Pharmaceuticals、Allergan、Novartis、Merck、Santen Pharmaceutical、Shire、Alcon、Bausch Health Companies、Johnson and Johnson、VISUfarma

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、ドライアイ治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なドライアイ治療薬メーカーの企業概要、2019年~2022年までのドライアイ治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なドライアイ治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別ドライアイ治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのドライアイ治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのドライアイ治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびドライアイ治療薬の産業チェーンを掲載しています。
・第13、14、15章では、ドライアイ治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ドライアイ治療薬の概要
- 種類別分析(2017年vs2021年vs2028年):抗炎症薬、人工涙液、涙点プラグ、分泌促進薬、その他
- 用途別分析(2017年vs2021年vs2028年):病院、薬局、眼科クリニック、小売店、オンライン薬局
- 世界のドライアイ治療薬市場規模・予測
- 世界のドライアイ治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- EyeGate Pharmaceuticals、Allergan、Novartis、Merck、Santen Pharmaceutical、Shire、Alcon、Bausch Health Companies、Johnson and Johnson、VISUfarma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:抗炎症薬、人工涙液、涙点プラグ、分泌促進薬、その他
・用途別分析2017年-2028年:病院、薬局、眼科クリニック、小売店、オンライン薬局
・ドライアイ治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・ドライアイ治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・ドライアイ治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ドライアイ治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・ドライアイ治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dry Eye Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dry Eye Medication market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Dry Eye Medication global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-inflammatory Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dry Eye Medication include EyeGate Pharmaceuticals, Allergan, Novartis, Merck, and Santen Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dry Eye Medication market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-inflammatory Drugs
Artificial Tears
Punctal Plugs
Secretagogues
Others
Market segment by Application can be divided into
Hospital
Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies
The key market players for global Dry Eye Medication market are listed below:
EyeGate Pharmaceuticals
Allergan
Novartis
Merck
Santen Pharmaceutical
Shire
Alcon
Bausch Health Companies
Johnson and Johnson
VISUfarma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Eye Medication product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dry Eye Medication, with price, sales, revenue and global market share of Dry Eye Medication from 2019 to 2022.
Chapter 3, the Dry Eye Medication competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Eye Medication breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dry Eye Medication market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dry Eye Medication.
Chapter 13, 14, and 15, to describe Dry Eye Medication sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Dry Eye Medication Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dry Eye Medication Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Anti-inflammatory Drugs
1.2.3 Artificial Tears
1.2.4 Punctal Plugs
1.2.5 Secretagogues
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dry Eye Medication Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacies
1.3.4 Eye Health Clinics
1.3.5 Retail Pharmacies
1.3.6 Online Pharmacies
1.4 Global Dry Eye Medication Market Size & Forecast
1.4.1 Global Dry Eye Medication Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dry Eye Medication Sales in Volume (2017-2028)
1.4.3 Global Dry Eye Medication Price (2017-2028)
1.5 Global Dry Eye Medication Production Capacity Analysis
1.5.1 Global Dry Eye Medication Total Production Capacity (2017-2028)
1.5.2 Global Dry Eye Medication Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dry Eye Medication Market Drivers
1.6.2 Dry Eye Medication Market Restraints
1.6.3 Dry Eye Medication Trends Analysis
2 Manufacturers Profiles
2.1 EyeGate Pharmaceuticals
2.1.1 EyeGate Pharmaceuticals Details
2.1.2 EyeGate Pharmaceuticals Major Business
2.1.3 EyeGate Pharmaceuticals Dry Eye Medication Product and Services
2.1.4 EyeGate Pharmaceuticals Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Dry Eye Medication Product and Services
2.2.4 Allergan Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Dry Eye Medication Product and Services
2.3.4 Novartis Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Dry Eye Medication Product and Services
2.4.4 Merck Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Santen Pharmaceutical
2.5.1 Santen Pharmaceutical Details
2.5.2 Santen Pharmaceutical Major Business
2.5.3 Santen Pharmaceutical Dry Eye Medication Product and Services
2.5.4 Santen Pharmaceutical Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Shire
2.6.1 Shire Details
2.6.2 Shire Major Business
2.6.3 Shire Dry Eye Medication Product and Services
2.6.4 Shire Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Alcon
2.7.1 Alcon Details
2.7.2 Alcon Major Business
2.7.3 Alcon Dry Eye Medication Product and Services
2.7.4 Alcon Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bausch Health Companies
2.8.1 Bausch Health Companies Details
2.8.2 Bausch Health Companies Major Business
2.8.3 Bausch Health Companies Dry Eye Medication Product and Services
2.8.4 Bausch Health Companies Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Dry Eye Medication Product and Services
2.9.4 Johnson and Johnson Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 VISUfarma
2.10.1 VISUfarma Details
2.10.2 VISUfarma Major Business
2.10.3 VISUfarma Dry Eye Medication Product and Services
2.10.4 VISUfarma Dry Eye Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dry Eye Medication Breakdown Data by Manufacturer
3.1 Global Dry Eye Medication Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dry Eye Medication Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dry Eye Medication
3.4 Market Concentration Rate
3.4.1 Top 3 Dry Eye Medication Manufacturer Market Share in 2021
3.4.2 Top 6 Dry Eye Medication Manufacturer Market Share in 2021
3.5 Global Dry Eye Medication Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dry Eye Medication Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dry Eye Medication Market Size by Region
4.1.1 Global Dry Eye Medication Sales in Volume by Region (2017-2028)
4.1.2 Global Dry Eye Medication Revenue by Region (2017-2028)
4.2 North America Dry Eye Medication Revenue (2017-2028)
4.3 Europe Dry Eye Medication Revenue (2017-2028)
4.4 Asia-Pacific Dry Eye Medication Revenue (2017-2028)
4.5 South America Dry Eye Medication Revenue (2017-2028)
4.6 Middle East and Africa Dry Eye Medication Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dry Eye Medication Sales in Volume by Type (2017-2028)
5.2 Global Dry Eye Medication Revenue by Type (2017-2028)
5.3 Global Dry Eye Medication Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dry Eye Medication Sales in Volume by Application (2017-2028)
6.2 Global Dry Eye Medication Revenue by Application (2017-2028)
6.3 Global Dry Eye Medication Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dry Eye Medication Sales by Type (2017-2028)
7.2 North America Dry Eye Medication Sales by Application (2017-2028)
7.3 North America Dry Eye Medication Market Size by Country
7.3.1 North America Dry Eye Medication Sales in Volume by Country (2017-2028)
7.3.2 North America Dry Eye Medication Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dry Eye Medication Sales by Type (2017-2028)
8.2 Europe Dry Eye Medication Sales by Application (2017-2028)
8.3 Europe Dry Eye Medication Market Size by Country
8.3.1 Europe Dry Eye Medication Sales in Volume by Country (2017-2028)
8.3.2 Europe Dry Eye Medication Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dry Eye Medication Sales by Type (2017-2028)
9.2 Asia-Pacific Dry Eye Medication Sales by Application (2017-2028)
9.3 Asia-Pacific Dry Eye Medication Market Size by Region
9.3.1 Asia-Pacific Dry Eye Medication Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dry Eye Medication Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dry Eye Medication Sales by Type (2017-2028)
10.2 South America Dry Eye Medication Sales by Application (2017-2028)
10.3 South America Dry Eye Medication Market Size by Country
10.3.1 South America Dry Eye Medication Sales in Volume by Country (2017-2028)
10.3.2 South America Dry Eye Medication Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dry Eye Medication Sales by Type (2017-2028)
11.2 Middle East & Africa Dry Eye Medication Sales by Application (2017-2028)
11.3 Middle East & Africa Dry Eye Medication Market Size by Country
11.3.1 Middle East & Africa Dry Eye Medication Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dry Eye Medication Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dry Eye Medication and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dry Eye Medication
12.3 Dry Eye Medication Production Process
12.4 Dry Eye Medication Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dry Eye Medication Typical Distributors
13.3 Dry Eye Medication Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Dry Eye Medication Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dry Eye Medication Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. EyeGate Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. EyeGate Pharmaceuticals Major Business
Table 5. EyeGate Pharmaceuticals Dry Eye Medication Product and Services
Table 6. EyeGate Pharmaceuticals Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Dry Eye Medication Product and Services
Table 10. Allergan Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Dry Eye Medication Product and Services
Table 14. Novartis Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Dry Eye Medication Product and Services
Table 18. Merck Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Santen Pharmaceutical Major Business
Table 21. Santen Pharmaceutical Dry Eye Medication Product and Services
Table 22. Santen Pharmaceutical Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Shire Basic Information, Manufacturing Base and Competitors
Table 24. Shire Major Business
Table 25. Shire Dry Eye Medication Product and Services
Table 26. Shire Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Alcon Basic Information, Manufacturing Base and Competitors
Table 28. Alcon Major Business
Table 29. Alcon Dry Eye Medication Product and Services
Table 30. Alcon Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table 32. Bausch Health Companies Major Business
Table 33. Bausch Health Companies Dry Eye Medication Product and Services
Table 34. Bausch Health Companies Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 36. Johnson and Johnson Major Business
Table 37. Johnson and Johnson Dry Eye Medication Product and Services
Table 38. Johnson and Johnson Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. VISUfarma Basic Information, Manufacturing Base and Competitors
Table 40. VISUfarma Major Business
Table 41. VISUfarma Dry Eye Medication Product and Services
Table 42. VISUfarma Dry Eye Medication Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Dry Eye Medication Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Dry Eye Medication Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Dry Eye Medication, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Dry Eye Medication Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Dry Eye Medication Production Site of Key Manufacturer
Table 48. Dry Eye Medication New Entrant and Capacity Expansion Plans
Table 49. Dry Eye Medication Mergers & Acquisitions in the Past Five Years
Table 50. Global Dry Eye Medication Sales by Region (2017-2022) & (K Units)
Table 51. Global Dry Eye Medication Sales by Region (2023-2028) & (K Units)
Table 52. Global Dry Eye Medication Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Dry Eye Medication Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Dry Eye Medication Sales by Type (2017-2022) & (K Units)
Table 55. Global Dry Eye Medication Sales by Type (2023-2028) & (K Units)
Table 56. Global Dry Eye Medication Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Dry Eye Medication Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Dry Eye Medication Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Dry Eye Medication Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Dry Eye Medication Sales by Application (2017-2022) & (K Units)
Table 61. Global Dry Eye Medication Sales by Application (2023-2028) & (K Units)
Table 62. Global Dry Eye Medication Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Dry Eye Medication Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Dry Eye Medication Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Dry Eye Medication Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Dry Eye Medication Sales by Country (2017-2022) & (K Units)
Table 67. North America Dry Eye Medication Sales by Country (2023-2028) & (K Units)
Table 68. North America Dry Eye Medication Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Dry Eye Medication Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Dry Eye Medication Sales by Type (2017-2022) & (K Units)
Table 71. North America Dry Eye Medication Sales by Type (2023-2028) & (K Units)
Table 72. North America Dry Eye Medication Sales by Application (2017-2022) & (K Units)
Table 73. North America Dry Eye Medication Sales by Application (2023-2028) & (K Units)
Table 74. Europe Dry Eye Medication Sales by Country (2017-2022) & (K Units)
Table 75. Europe Dry Eye Medication Sales by Country (2023-2028) & (K Units)
Table 76. Europe Dry Eye Medication Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Dry Eye Medication Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Dry Eye Medication Sales by Type (2017-2022) & (K Units)
Table 79. Europe Dry Eye Medication Sales by Type (2023-2028) & (K Units)
Table 80. Europe Dry Eye Medication Sales by Application (2017-2022) & (K Units)
Table 81. Europe Dry Eye Medication Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Dry Eye Medication Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Dry Eye Medication Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Dry Eye Medication Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Dry Eye Medication Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Dry Eye Medication Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Dry Eye Medication Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Dry Eye Medication Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Dry Eye Medication Sales by Application (2023-2028) & (K Units)
Table 90. South America Dry Eye Medication Sales by Country (2017-2022) & (K Units)
Table 91. South America Dry Eye Medication Sales by Country (2023-2028) & (K Units)
Table 92. South America Dry Eye Medication Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Dry Eye Medication Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Dry Eye Medication Sales by Type (2017-2022) & (K Units)
Table 95. South America Dry Eye Medication Sales by Type (2023-2028) & (K Units)
Table 96. South America Dry Eye Medication Sales by Application (2017-2022) & (K Units)
Table 97. South America Dry Eye Medication Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Dry Eye Medication Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Dry Eye Medication Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Dry Eye Medication Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Dry Eye Medication Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Dry Eye Medication Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Dry Eye Medication Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Dry Eye Medication Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Dry Eye Medication Sales by Application (2023-2028) & (K Units)
Table 106. Dry Eye Medication Raw Material
Table 107. Key Manufacturers of Dry Eye Medication Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Dry Eye Medication Typical Distributors
Table 111. Dry Eye Medication Typical Customers
List of Figures
Figure 1. Dry Eye Medication Picture
Figure 2. Global Dry Eye Medication Revenue Market Share by Type in 2021
Figure 3. Anti-inflammatory Drugs
Figure 4. Artificial Tears
Figure 5. Punctal Plugs
Figure 6. Secretagogues
Figure 7. Others
Figure 8. Global Dry Eye Medication Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Pharmacies
Figure 11. Eye Health Clinics
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global Dry Eye Medication Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Dry Eye Medication Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Dry Eye Medication Sales (2017-2028) & (K Units)
Figure 17. Global Dry Eye Medication Price (2017-2028) & (US$/Unit)
Figure 18. Global Dry Eye Medication Production Capacity (2017-2028) & (K Units)
Figure 19. Global Dry Eye Medication Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Dry Eye Medication Market Drivers
Figure 21. Dry Eye Medication Market Restraints
Figure 22. Dry Eye Medication Market Trends
Figure 23. Global Dry Eye Medication Sales Market Share by Manufacturer in 2021
Figure 24. Global Dry Eye Medication Revenue Market Share by Manufacturer in 2021
Figure 25. Dry Eye Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Dry Eye Medication Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Dry Eye Medication Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Dry Eye Medication Sales Market Share by Region (2017-2028)
Figure 29. Global Dry Eye Medication Revenue Market Share by Region (2017-2028)
Figure 30. North America Dry Eye Medication Revenue (2017-2028) & (USD Million)
Figure 31. Europe Dry Eye Medication Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Dry Eye Medication Revenue (2017-2028) & (USD Million)
Figure 33. South America Dry Eye Medication Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Dry Eye Medication Revenue (2017-2028) & (USD Million)
Figure 35. Global Dry Eye Medication Sales Market Share by Type (2017-2028)
Figure 36. Global Dry Eye Medication Revenue Market Share by Type (2017-2028)
Figure 37. Global Dry Eye Medication Price by Type (2017-2028) & (US$/Unit)
Figure 38. Global Dry Eye Medication Sales Market Share by Application (2017-2028)
Figure 39. Global Dry Eye Medication Revenue Market Share by Application (2017-2028)
Figure 40. Global Dry Eye Medication Price by Application (2017-2028) & (US$/Unit)
Figure 41. North America Dry Eye Medication Sales Market Share by Type (2017-2028)
Figure 42. North America Dry Eye Medication Sales Market Share by Application (2017-2028)
Figure 43. North America Dry Eye Medication Sales Market Share by Country (2017-2028)
Figure 44. North America Dry Eye Medication Revenue Market Share by Country (2017-2028)
Figure 45. United States Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Dry Eye Medication Sales Market Share by Type (2017-2028)
Figure 49. Europe Dry Eye Medication Sales Market Share by Application (2017-2028)
Figure 50. Europe Dry Eye Medication Sales Market Share by Country (2017-2028)
Figure 51. Europe Dry Eye Medication Revenue Market Share by Country (2017-2028)
Figure 52. Germany Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Dry Eye Medication Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Dry Eye Medication Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Dry Eye Medication Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Dry Eye Medication Revenue Market Share by Region (2017-2028)
Figure 61. China Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Dry Eye Medication Sales Market Share by Type (2017-2028)
Figure 68. South America Dry Eye Medication Sales Market Share by Application (2017-2028)
Figure 69. South America Dry Eye Medication Sales Market Share by Country (2017-2028)
Figure 70. South America Dry Eye Medication Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Dry Eye Medication Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Dry Eye Medication Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Dry Eye Medication Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Dry Eye Medication Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Dry Eye Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Dry Eye Medication in 2021
Figure 82. Manufacturing Process Analysis of Dry Eye Medication
Figure 83. Dry Eye Medication Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO19278 )"世界のドライアイ治療薬市場2022年:市場規模予測(~2028年)" (英文:Global Dry Eye Medication Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。